microdosing glp 1 for longevity GLP-1: A Next-Generation Approach to Metabolic and Medicine: Shamsah Amersi, MD: OB-GYNs People Are Microdosing Weight-Loss Drugs

Since metabolic health and mental health are closely linked, GLP-1s may provide a dual benefit for individuals struggling with both obesity and depression

This makes it different from semaglutide (which mimics GLP-1) and tirzepatide (which mimics GLP-1 and GIP)

Tirzepatide is a dual-agonist (GLP-1 + GIP)

as an adjunct to diet and exercise regimen to improve glycemic control in patients with type 2 diabetes mellitus who did not achieve adequate control against the background of monotherapy with metformin or sitagliptin, or after unsuccessful combined treatment with two drugs

Certain over-the-counter products marketed for weight loss may do more harm than goodand in some cases, they may be dangerous

Back Thorens, B, Porret, A, Bhler, L, et al (Nov 1993) Cloning and functional expression of the human islet GLP-1 receptor